John Rosling is listed as an executive officer and director on 3 SEC Form D filings by 2 issuers between Aug 2013 and Nov 2014: Aminex Therapeutics, Inc. (Kenmore, WA — biotechnology — 2014; $15.1M reported sold to 162 investors) and MQT Holdings, LLC (Seattle, WA — pharmaceuticals — 2013; $250K reported sold to 16 investors).
What this means 2 separate companies raised money with this person listed as executive officer and director. Across those companies the filings report $15.3M sold in total.
Listed alongside James Skaggs (2 shared filings), Mark Burns (2 shared filings), Thomas Graham (2 shared filings), Donald Mowat (1 shared filing), Jeff Miller (1 shared filing) and 2 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around John. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 3 public filings for John Rosling and found 2 differences: No amendment in the last 12 months on an offering that may still be open; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.